Published online Feb 16, 2014. doi: 10.4253/wjge.v6.i2.55
Revised: December 18, 2013
Accepted: January 7, 2014
Published online: February 16, 2014
Processing time: 205 Days and 11.1 Hours
AIM: To evaluate the feasibility of using an automated spring-loaded needle device for endoscopic ultrasound (EUS)-guided abdominal paracentesis (EUS-P) to see if this would make it easier to puncture the mobile and lax gastric wall for EUS-P.
METHODS: The EUS database and electronic medical records at Fukushima Medical University Hospital were searched from January 2001 to April 2011. Patients with a history of cancer and who underwent EUS-P using an automated spring-loaded needle device with a 22-gauge puncture needle were included. The needle was passed through the instrument channel and advanced through the gastrointestinal wall under EUS guidance into the echo-free space in the abdominal cavity and ascitic fluid was collected. The confirmed diagnosis of malignant ascites included positive cytology and results from careful clinical observation for at least 6 mo in patients with negative cytology. The technical success rate, cytology results and complications were evaluated.
RESULTS: We found 11 patients who underwent EUS-P with an automated spring-loaded needle device. In 4 cases, ascites was revealed only with EUS but not in other imaging modalities. EUS-P was done in 7 other cases because there was minimal ascitic fluid and no safe window for percutaneous abdominal aspiration. Ascitic fluid was obtained in all cases by EUS-P. The average amount aspirated was 14.1 mL (range 0.5-38 mL) and that was sent for cytological exam. The etiology of ascitic fluid was benign in 5 patients and malignant in 6. In all cases, ascitic fluid was obtained with the first needle pass. No procedure-related adverse effects occurred.
CONCLUSION: EUS-P with an automated spring-loaded needle device is a feasible and safe method for ascites evaluation.
Core tip: Even in patients with a minute amount of ascitic fluid, an automated spring-loaded needle device enabled us to perform endoscopic ultrasound (EUS)-guided abdominal paracentesis (EUS-P) readily, which has the potential to play an important role for staging of cancer since the establishment of malignant ascites denotes a more advanced stage of cancer.